Cargando…

Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer

Prostate cancer is the second most common male malignancy, with a highly variable clinical presentation and outcome. Therefore, diagnosis, prognostication, and management remain a challenge, as available clinical, imaging, and pathological parameters provide limited risk assessment. Thus, many bioma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flores, Bianca C. T., Correia, Margareta P., Rodríguez, José G., Henrique, Rui, Jerónimo, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391503/ https://www.ncbi.nlm.nih.gov/pubmed/34439363 http://dx.doi.org/10.3390/cancers13164209

Ejemplares similares

Epigenetic modulation and prostate cancer: Paving the way for NK cell anti-tumor immunity
por: dos Reis, Filipa D., et al.
Publicado: (2023)

Renal Cell Tumors: Uncovering the Biomarker Potential of ncRNAs
por: Outeiro-Pinho, Gonçalo, et al.
Publicado: (2020)

Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer
por: Lopes, Nair, et al.
Publicado: (2021)

Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines
por: Pacheco, Mariana Brütt, et al.
Publicado: (2021)

Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?
por: Couto-Cunha, Anabela, et al.
Publicado: (2022)

A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA
por: Salta, Sofia, et al.
Publicado: (2018)

Epigenetic Alterations in Oesophageal Cancer: Expression and Role of the Involved Enzymes
por: Lopes, Nair, et al.
Publicado: (2020)

DNA Methylation as a Therapeutic Target for Bladder Cancer
por: Nunes, Sandra P., et al.
Publicado: (2020)

Characterization of DNA Methylation in Circulating Tumor Cells
por: Pixberg, Constantin F., et al.
Publicado: (2015)

Targeting DNA Methyltranferases in Urological Tumors
por: Marques-Magalhães, Ângela, et al.
Publicado: (2018)

Bridging the gap between prostate radiology and pathology through machine learning
por: Bhattacharya, Indrani, et al.
Publicado: (2022)

The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors
por: Lobo, João, et al.
Publicado: (2018)

DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
por: Constâncio, Vera, et al.
Publicado: (2020)

Profiling DNA Methylation Based on Next-Generation Sequencing Approaches: New Insights and Clinical Applications
por: Barros-Silva, Daniela, et al.
Publicado: (2018)

DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand?
por: Tavares, Nuno Tiago, et al.
Publicado: (2022)

Bridging the gap
Publicado: (2018)

Bridging the gap
por: Armitage, Sarah K, et al.
Publicado: (2016)

Bridging the Gap
por: Halpin, Hilary
Publicado: (1958)

Bridging the Gap
por: Whisenant, Brian, et al.
Publicado: (2023)

Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development
por: Yu, Weihua, et al.
Publicado: (2022)

Epigenetic Markers for Molecular Detection of Prostate Cancer
por: Costa, Vera L., et al.
Publicado: (2007)

Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma
por: Sequeira, José Pedro, et al.
Publicado: (2021)

Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction
por: Bidarra, David, et al.
Publicado: (2019)

DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis
por: Salta, Sofia, et al.
Publicado: (2023)

Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling
por: Macedo-Silva, Catarina, et al.
Publicado: (2023)

From Therapy Resistance to Targeted Therapies in Prostate Cancer
por: Moreira-Silva, Filipa, et al.
Publicado: (2022)

MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors
por: Torres-Ferreira, Jorge, et al.
Publicado: (2017)

Methyl-RNA: an evolutionary bridge between RNA and DNA?
por: Poole, Anthony, et al.
Publicado: (2000)

Bridging the Gap in Access to Care for Children With CNS Tumors Worldwide
por: Moreira, Daniel C., et al.
Publicado: (2020)

Bridging the Values Gap
por: Freeman, R
Publicado: (2015)

Bridging the Gap between Gut Microbial Dysbiosis and Cardiovascular Diseases
por: Lau, Kimberley, et al.
Publicado: (2017)

Bridging the gap between atlastin conformations
por: Short, Ben
Publicado: (2011)

Bridging the gap between health and justice
por: Gideon, Lior
Publicado: (2013)

Bridging the gap between sister kinetochores
por: Tolić, Iva M., et al.
Publicado: (2016)

Bridging the Gap Between Conservation and Health
por: Yang, Angela, et al.
Publicado: (2015)

Ancient DNA from lake sediments: Bridging the gap between paleoecology and genetics
por: Anderson-Carpenter, Lynn L, et al.
Publicado: (2011)

Bridging the gap : articles on mexican literature
por: Spell, Jefferson Rea, 1886-
Publicado: (1971)

Taxonomic discoveries bridging the gap between our knowledge and biodiversity
por: Jin, Xiao-Hua, et al.
Publicado: (2018)

Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer
por: Ramalho-Carvalho, João, et al.
Publicado: (2017)

A DNA methylation-based test for esophageal cancer detection
por: Salta, Sofia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j2m2ajhsjemspvbdh5biaeqg0t